Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment

CH Liu; CY Chen; WW Su; KC Tseng; CC Lo; CJ Liu; JJ Chen; CY Peng; YL Shih; SS Yang; CS Huang; KJ Huang; CY Chang; MC Tsai; Wei-Yu Kao; YJ Fang; PY Chen; PY Su; CW Tseng; JJ Huang; PL Lee; HC Lai; TY Hsieh; CH Chang; YJ Huang; FJ Lee; CC Chang; JH Kao

Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment

CH Liu , CY Chen , WW Su , KC Tseng , CC Lo , CJ Liu, JJ Chen , CY Peng, YL Shih, SS Yang, CS Huang, KJ Huang, CY Chang, MC Tsai , Wei-Yu Kao, YJ Fang, PY Chen, PY Su, CW Tseng, JJ HuangPL Lee, HC Lai, TY Hsieh, CH Chang, YJ Huang, FJ Lee, CC Chang, JH Kao

研究成果: 雜誌貢獻 › 文章 › 同行評審

原文	英語
期刊	Gut
出版狀態	已發佈 - 2021

UN SDG

此研究成果有助於以下永續發展目標

引用此

Liu , CH., Chen , CY., Su , WW., Tseng , KC., Lo , CC., Liu, CJ., Chen , JJ., Peng, CY., Shih, YL., Yang, SS., Huang, CS., Huang, KJ., Chang, CY., Tsai , MC., Kao, W.-Y., Fang, YJ., Chen, PY., Su, PY., Tseng, CW., ... Kao , JH. (2021). Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment. Gut.

Liu , CH, Chen , CY, Su , WW, Tseng , KC, Lo , CC, Liu, CJ, Chen , JJ, Peng, CY, Shih, YL, Yang, SS, Huang, CS, Huang, KJ, Chang, CY, Tsai , MC, Kao, W-Y, Fang, YJ, Chen, PY, Su, PY, Tseng, CW, Huang, JJ, Lee, PL, Lai, HC, Hsieh, TY, Chang, CH, Huang, YJ, Lee, FJ, Chang, CC & Kao , JH 2021, 'Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment', Gut.

@article{00fba7c7385545d884c5269efcc77dfe,

title = "Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment",

author = "CH Liu and CY Chen and WW Su and KC Tseng and CC Lo and CJ Liu and JJ Chen and CY Peng and YL Shih and SS Yang and CS Huang and KJ Huang and CY Chang and MC Tsai and Wei-Yu Kao and YJ Fang and PY Chen and PY Su and CW Tseng and JJ Huang and PL Lee and HC Lai and TY Hsieh and CH Chang and YJ Huang and FJ Lee and CC Chang and JH Kao",

year = "2021",

language = "English",

journal = "Gut",

issn = "0017-5749",

publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Sofosbuvir/velpatasvir with or without low-dose ribavirin for 12 weeks in patients with chronic hepatitis C virus infection and severe renal impairment

AU - Liu , CH

AU - Chen , CY

AU - Su , WW

AU - Tseng , KC

AU - Lo , CC

AU - Liu, CJ

AU - Chen , JJ

AU - Peng, CY

AU - Shih, YL

AU - Yang, SS

AU - Huang, CS

AU - Huang, KJ

AU - Chang, CY

AU - Tsai , MC

AU - Kao, Wei-Yu

AU - Fang, YJ

AU - Chen, PY

AU - Su, PY

AU - Tseng, CW

AU - Huang, JJ

AU - Lee, PL

AU - Lai, HC

AU - Hsieh, TY

AU - Chang, CH

AU - Huang, YJ

AU - Lee, FJ

AU - Chang, CC

AU - Kao , JH

PY - 2021

Y1 - 2021

M3 - Article

SN - 0017-5749

JO - Gut

JF - Gut

ER -